BSND p.Gly47=
c.141G>C · rs76222905 · VCV722781
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.4 | GERP -0.91, phastCons 1 |
| Overall | ||
| CADD | 9.101 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.175% | 570 |
| Remaining individualsnot grpmax-eligible | 0.0769% | 1,301 |
| European (non-Finnish)grpmax | 0.0691% | 1,447 |
| African / African-American | 0.0107% | 9,378 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00676% | 14,800 |
| Admixed American | 0.00667% | 15,001 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BSND
- Protein
- p.Gly47=
- Coding
- c.141G>C
- MANE Select
- NM_057176
- dbSNP
- rs76222905
- Type
- single nucleotide variant
- Location
- chr1:54999327 (GRCh38)
- Gene constraint
- LOEUF 1.03 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 53.80
- Residue 47
- a UniProt-annotated variant site (in barts4a); a UniProt-annotated variant site (in barts4a; loss of clcnka and clcnkb channel conductance); a UniProt-annotated variant site (in barts4a; atypical; decreases the number of channels; almost complete loss of ion conductance); the 'regulates channel membrane trafficking and ion conductance' region
Disease context
Bartter syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Bartter syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, X-linked recessive
- Onset
- Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- BSND p.Gly47Arg Pathogenic/Likely pathogenic ★★ same residue
- BSND c.178-2A>C Likely pathogenic ★★ same condition
- BSND c.272+1G>T Pathogenic/Likely pathogenic ★★ same condition
- BSND p.Arg8Trp Pathogenic/Likely pathogenic ★★ same condition
- BSND p.Gln95Ter Pathogenic/Likely pathogenic ★★ same condition
- BSND p.Glu148Ter Pathogenic/Likely pathogenic ★★ same condition
- BSND p.Glu4Ter Pathogenic ★★ same condition
- BSND p.Glu88Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bsnd-p-gly47 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown